share_log

HC Wainwright & Co. Maintains Buy on Armata Pharmaceuticals, Maintains $7 Price Target

Benzinga ·  Mar 22 22:58

HC Wainwright & Co. analyst Joseph Pantginis maintains Armata Pharmaceuticals (AMEX:ARMP) with a Buy and maintains $7 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment